Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Reduce Blood Loss and Transfusion Requirements? A Double-blinded Randomized Controlled Trial

NCT05024253 is registered in ClinicalTrials.gov with Children's Cancer Hospital Egypt 57357 as lead sponsor.

NCT NCT05024253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05024253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Reduce Blood Loss and Transfusion Requirements? A Double-blinded Randomized Controlled Trial
Lead sponsor
Children's Cancer Hospital Egypt 57357
Phase
Phase 3
Overall status
Completed
Start date
August 2, 2021
Completion date
February 1, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma of bone, osteosarcoma